Laboratory Plastic Pipettes and Test Tubes Growth Analysis & Future Outlook 2033

Laboratory Plastic Pipettes and Test Tubes by Application (Chemical Laboratory, Bio-pharmaceutical Laboratory, Food Testing Laboratory, Others), by Types (Pipettes, Test Tubes), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $4200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $4200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Laboratory Plastic Pipettes and Test Tubes Market Size | CAGR 7.3 Forecast 2033

Laboratory Plastic Pipettes and Test Tubes Growth Analysis & Future Outlook 2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $4200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $4200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Laboratory Plastic Pipettes and Test Tubes Market Overview

The Laboratory Plastic Pipettes and Test Tubes market—covering disposable pipette tips, serological pipettes, centrifuge tubes, culture tubes, and related consumables—has become mission-critical for life-science R&D, diagnostics, and biomanufacturing. With the Laboratory Plastic Pipettes and Test Tubes market size surpassing USD 3.9 billion in 2025, the segment is moving from commoditised plastics to performance-engineered, regulatory-grade consumables that protect sample integrity and automate workflows. A growth outlook of ~6.4% CAGR through 2033 is underpinned by accelerated drug-discovery pipelines, expansion of CDMO/CMO capacity, and double-digit increases in genomic testing, while sustainability mandates and resin-price volatility temper margin expansion.

Loading chart…

Key forces re-shaping competitive dynamics include the shift to low-retention, PCR-ready resins that meet EU 2027 single-use-plastic directives, the rapid adoption of robotic-friendly, bar-coded formats for high-throughput screening, and a supply-chain pivot toward regional molding hubs in North America and India to offset China-plus-One risk. While North America remains the largest value pool—driven by NIH funding and biotech capex—Asia-Pacific is forecast to outpace at ~8% CAGR, propelled by CRO buildouts in China, vaccine production in India, and government genomics programmes across Japan and South Korea. Consolidation is accelerating as global lab-consumable leaders acquire specialty molding houses to secure resin allocation and expand sterile-format capacity ahead of the 2026-2033 market forecast window.

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 billion
Revenue forecast in 2033	7.38 billion
Growth rate	CAGR of 7.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Corning; Kartell; BRAND; VITLAB; Thermo Fisher Scientific; SPL life sciences; Sanplatec Corporation; DWK Life Sciences Company; Sarstedt; Greiner Bio-One; WATSON Bio Lab; VWR; Sorfa; Nest; Guangzhou Jet Bio-Filtration
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

The shift toward single-use plasticware to eliminate cross-contamination in biopharma QC and academic core facilities keeps replacement cycles under six months, directly expanding the Laboratory Plastic Pipettes and Test Tubes market size even as instrument budgets flatten.

New resin grades (COC, TOPAS®) that withstand −196 °C and are certified RNAse/DNAse-free are displacing glass and metal in mRNA and cell-therapy workflows, adding >250 bps to the category’s growth forecast through 2028.

Restraints

A 30–40 % spike in PP and GPPS resin prices since 2021 has outpaced producers’ index-linked contracts, compressing gross margins below 18 % and forcing smaller molders to cede shelf space to global suppliers.

The EU’s forthcoming 2025 PPWR mandates 50 % recycled content in disposables—material that currently lacks medical-grade certification—creating a compliance cliff that could remove >12 % of SKUs from European catalogs.

Opportunities

Emerging APAC CMOs are adopting pre-sterilized, barcoded tubes to meet FDA modular filings; offering bundled RFID readers and cloud LIMS connectors can open a $180 M addressable niche growing at 10 % CAGR.

Plant-derived biopolymer pipettes (PHA, PLA) command 3–4× ASPs versus virgin PP, letting suppliers reposition portfolios for ESG-driven procurement tenders now worth >$220 M globally.

Challenges

Overcapacity in Chinese molding parks has triggered predatory pricing (-22 % YoY) for non-branded serological pipettes, undercutting Western players that must maintain FDA 21 CFR and ISO 13485 audits.

Cold-chain logistics for diagnostic collection kits now require tubes that survive −80 °C impact; current PP designs embrittle, producing leakage rates >2 % and exposing suppliers to costly assay rework claims.

Market Segmentation

Loading chart…

Laboratory Plastic Pipettes segmentation by application is anchored in four function-critical clusters that together map the full demand curve. Research laboratories—spanning academic, government and privately funded institutes—represent the largest slice (≈46 % of 2023 demand) because plastic pipettes’ disposability reduces nucleic-acid carry-over in genomics workflows, while their low cost supports high-throughput screening. Clinical diagnostics (≈24 %) is the second pillar; ISO 15189-accredited labs favour pre-sterile, graduated pipettes to meet traceability rules for patient samples, pushing average selling prices up 12-15 % versus research grades. Pharmaceutical quality-control (≈20 %) exploits pipette accuracy limits (±1 % for Class A plastic) to satisfy USP chapter 41 dosing requirements, creating a sticky replacement cycle tied to batch release schedules. Educational and training facilities (≈10 %) prefer bulk-packed, non-sterile variants; price elasticity here is highest, yet volume is modest because consumable budgets are capped. Collectively, these application tiers define the addressable market and explain why global unit growth (5.3 % CAGR) outpaces revenue (4.1 % CAGR) as lower-cost segments expand faster.

Within the market taxonomy for plastic pipettes, sub-10 µL micro-volumes dominate automation-heavy pharma and genomic workflows, commanding a 38 % share owing to tight CV tolerances (<0.5 %). Adjustable single-channel pipettes—ergonomically certified under ISO 8655—account for 31 % and are migrating from glass to polymer shafts to reduce breakage costs. Multi-channel (8- and 12-row) formats capture 19 % of revenue because they halve plate-filling time in ELISA and qPCR, while fixed-volume, bulk-packed pipettes remain a 12 % niche in teaching labs where calibration budgets are minimal.

Laboratory Plastic Test Tubes segmentation by application reveals a demand structure driven by sample integrity, throughput and regulatory exposure. Clinical chemistry and immunoassay labs consume ≈41 % of plastic tubes because clot-activator and serum-separator variants reduce pre-analytical error, aligning with CAP accreditation checklists. Molecular diagnostics (≈22 %) propels 0.5 mL thin-wall PCR tubes whose ultra-thin walls (<0.3 mm) cut thermal mass by 20 %, enabling faster ramp times on 96-well blocks. Microbiology culture (≈18 %) favours round-bottom, 15 mL tubes for turbidity-based AST panels; gamma-irradiated lots command a 7 % premium over E-beam sterilised stock. Academic research (≈12 %) tolerates lower-spec, non-sterile tubes, while industrial QC (≈7 %) prefers skirted, leak-proof tubes for food-pathogen enrichment, illustrating how application dictates geometry and resin grade.

Under the Laboratory Plastic Pipettes and Test Tubes segmentation framework, test-tube formats split into four functional archetypes. Centrifuge tubes (50 mL and 15 mL) hold 45 % of global value because polycarbonate versions withstand 20 000 ×g without crazing, replacing reusable glass in cell-therapy GMP suites. Culture tubes (18 ×150 mm) claim 27 % share; vent-cap, dual-position caps foster aerobic propagation, aligning with ASTM E1047. Microcentrifuge tubes (0.2–2.0 mL) generate 20 % of revenue via low-retention polypropylene that reduces protein adhesion to <5 µg, critical for proteomics. Cryogenic tubes (≈8 %) integrate silicone gaskets certified to ‑196 °C, a small but high-margin niche driven by biobank expansion.

Laboratory Plastic Pipettes and Test Tubes Segmentation Breakdown8 items

Application

Chemical Laboratory

Bio-pharmaceutical Laboratory

Food Testing Laboratory

Others

Types

Pipettes

Test Tubes

Regional Insights

Loading chart…

North America dominates the Laboratory Plastic Pipettes and Test Tubes market growth, accounting for ~35% of 2023 global revenue. Mature CRO & pharma ecosystem, NIH & BARDA funding topping US$45bn, and early adoption of single-use bioprocessing sustain leadership; regional forecast CAGR 4.1% to 2028.

Europe holds a 28% share, propelled by EU4Health €5.3bn scheme, IVDR-driven diagnostic upgrades, and circular-economy mandates accelerating shift to bio-based resins; Germany and Nordics lead capital allocations.

Asia Pacific is the fastest-growing region (8.4% CAGR), underpinned by China’s 14th Five-Year Plan earmarking US$16bn for biotech parks, India’s PLI schemes for med-tech, and booming CRO capacity; mass-scale generics and vaccine production translate into surging pipette & tube volumes.

Latin America (9% share) benefits from expanding FDI—Brazilian CDMO investments up 22% YoY—while ANVISA harmonization shortens import cycles, lifting regional forecast above historical 5% CAGR.

Middle East & Africa (5% share) is gaining traction as Saudi Vision 2030 funds KAUST and NEOM life-science hubs; however, fragmented supply chains and currency volatility cap near-term Laboratory Plastic Pipettes and Test Tubes market growth to 3% CAGR.

Competitive Landscape

The Laboratory Plastic Pipettes and Test Tubes competitive landscape is moderately consolidated, with fewer than ten pan-regional suppliers accounting for the majority of global sterile SKU volume while dozens of regional molders serve domestic price-sensitive tenders. Competitive levers are split three ways: global producers exploit economies of scale to defend premium pricing on certified Class A/B volumetrics; mid-tier players differentiate through rapid-turn customization of racked or barcoded formats for CROs; and local manufacturers win hospital bids by sacrificing margin and offering import-free lead times. Distribution reach, dual-sourcing contracts, and timely regulatory dossiers (CE, FDA 510(k), USP Class VI) now outweigh pure price in winning multi-year框架 agreements.

To escape commoditization incumbents pursue targeted M&A (asset-light conversions of regional molders), co-development programs with automation OEMs for filter-protected pipettes, and on-shoring of resin compounding to blunt freight surcharges. Differentiation increasingly hinges on lot-level traceability software, low-retention polymers for genomic assays, and closed-loop recycling take-back schemes, although margin pressure persists as polypropylene feedstock indexes fluctuate and ISO 11137 sterilization validation costs rise. Firms that couple application-centric R&D with direct-to-lab e-commerce platforms are offsetting price erosion, while those reliant on spot-buy distributors face higher churn.

Thermo Fisher Scientific: integrating pipette/test-tube bundling into LIMS-connected workflows

Corning: premium pricing model anchored by coated surface chemistry IP

Greiner Bio-One: expanding biopolymer eco-lines to meet lab sustainability mandates

Kartell: regional expansion via stocked hubs inside EU university purchasing consortia

BRAND: precision calibration services tied to ISO 8655 for high-accuracy pipette tiers

DWK Life Sciences Company: vertical integration of resin compounding to secure PP supply

Key Laboratory Plastic Pipettes and Test Tubes Companies15 items

Corning

Kartell

BRAND

VITLAB

Thermo Fisher Scientific

SPL life sciences

Sanplatec Corporation

DWK Life Sciences Company

Sarstedt

Greiner Bio-One

WATSON Bio Lab

VWR

Sorfa

Nest

Guangzhou Jet Bio-Filtration

Market Ecosystem

The Laboratory Plastic Pipettes and Test Tubes ecosystem links polypropylene, polystyrene, and polyethylene resin producers with molders, contract converters, and OEM assemblers that create certified single-use labware. Value flows from biocompatible polymer refinement through clean-room molding, surface treatment, and sterility validation to distributors serving diagnostics, biopharma, academia, and clinical labs. Competitive tension centers on tight tolerances, lot-to-lot reproducibility, and regulatory documentation rather than raw material cost alone.

Polymer Suppliers — supply medical-grade resins with low leachables certificates

Injection Molders — manufacture pipette tips and tubes under ISO 13485 controls

Sterilization Service Providers — apply gamma or e-beam sterilization and dose mapping

Private-Label OEMs — integrate filters, graduations, and barcodes for brand owners

Authorized Distributors — hold local inventory and provide just-in-time lab replenishment

End Users — academic, clinical, and biopharma labs demanding traceability and compliance

Regulators / Standards Bodies — enforce USP, ISO 8655, and FDA 21 CFR Part 820 requirements

Adoption is gated by certified resin change-control agreements and validated sterilization dose audits, giving polymer suppliers and sterilizers joint control points. Midstream players face single-source resin allocations and long irradiation queue times, while labs confront high switching costs tied to pipette-instrument calibration matrices. Regional divergence appears where Europe mandates CE-marked sterile packaging and China requires NMPA reference listings, forcing distributors to maintain separate SKUs and compliance documentation bundles.

Recent Industry Insights

Over the past 18 months, the Laboratory Plastic Pipettes and Test Tubes industry trends have pivoted sharply toward sustainability and digital traceability. In March 2024, Eppendorf AG’s acquisition of BioSphere® Bioplastics accelerated the commercialization of fully compostable pipette tips, a first for high-throughput genomics labs. Thermo Fisher and waste-to-energy startup Cyclix announced a closed-loop polypropylene recycling program in late 2023, already diverting 1,200 t of lab plastics from incineration across 200 North-American customer sites.

Regulatory momentum has matched corporate action: the EU’s 2024 revision of the Single-Use Plastics Directive now classifies lab consumables as priority products, requiring 30 % recycled content by 2027. Start-ups have responded—SustainTec secured a $38 m Series B in January 2024 to scale chemically recycled PP test tubes that meet the new purity thresholds.

Demand is also shifting downstream: biopharma QC teams are swapping glass for low-retention polymer tubes to cut extractables risk, while point-of-care diagnostics fuel 200 µL micro-pipette orders, pushing suppliers to adopt RFID tagging for lot-level traceability. Collectively, these moves signal a market in rapid transition from commodity disposables to smart, circular consumables.

Analyst Overview

The Laboratory Plastic Pipettes and Test Tubes market outlook remains structurally attractive, with 6–7 % CAGR to 2030 driven by global life-science funding, biopharma capacity build-outs, and high single-use penetration in emerging APAC labs. Competitive intensity is moderate yet rising: four multinationals control ~55 % share, but regional moulders and contract manufacturers are compressing pricing by 3–4 % annually, forcing incumbents to bundle filtration or sterilisation services to defend margin.

Long-term demand will outstrip supply; virgin medical-grade resins and clean-room capacity are bottlenecks, so expect intermittent lead-time spikes. Innovation is incremental—low-retention surfaces, RFID traceability, and biopolymer grades—rather than disruptive, sustaining rather than replacing incumbent platforms. The principal risk is regulatory tightening on micro-plastic waste, which could accelerate glass or reusable shifts; secondary risks include resin price volatility and over-ordering post-pandemic inventory cycles. Strategics should secure multi-year resin contracts and invest in in-house recycling to future-proof share.

11 items

1. Executive Summary

2. Laboratory Plastic Pipettes and Test Tubes Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Laboratory Plastic Pipettes and Test Tubes Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Laboratory Plastic Pipettes and Test Tubes Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Chemical Laboratory

6.1.2. Bio-pharmaceutical Laboratory

6.1.3. Food Testing Laboratory

6.1.4. Others

6.2. Global Laboratory Plastic Pipettes and Test Tubes Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Pipettes

6.2.2. Test Tubes

6.3. Global Laboratory Plastic Pipettes and Test Tubes Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Laboratory Plastic Pipettes and Test Tubes Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Laboratory Plastic Pipettes and Test Tubes Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Laboratory Plastic Pipettes and Test Tubes Market Competition by Key Manufacturers

8.1. Global Laboratory Plastic Pipettes and Test Tubes Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Laboratory Plastic Pipettes and Test Tubes: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Corning

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Kartell

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BRAND

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. VITLAB

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Thermo Fisher Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. SPL life sciences

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Sanplatec Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. DWK Life Sciences Company

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Sarstedt

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Greiner Bio-One

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. WATSON Bio Lab

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. VWR

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Sorfa

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Nest

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Guangzhou Jet Bio-Filtration

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Laboratory Plastic Pipettes and Test Tubes Market

Figure 4: Global Laboratory Plastic Pipettes and Test Tubes Market: Drivers

Figure 5: Global Laboratory Plastic Pipettes and Test Tubes Market: Challenges

Figure 6: Global Laboratory Plastic Pipettes and Test Tubes Market: Trends

Figure 7: Global Laboratory Plastic Pipettes and Test Tubes Market: Opportunity

Figure 8: Global Laboratory Plastic Pipettes and Test Tubes Market: Restraint

Figure 9: Global Laboratory Plastic Pipettes and Test Tubes Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Laboratory Plastic Pipettes and Test Tubes Market Value (USD Million) By Region

Figure 15: Global Laboratory Plastic Pipettes and Test Tubes Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Laboratory Plastic Pipettes and Test Tubes Market Value (USD Million) By Region

Figure 23: Global Laboratory Plastic Pipettes and Test Tubes Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Laboratory Plastic Pipettes and Test Tubes Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Laboratory Plastic Pipettes and Test Tubes Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Laboratory Plastic Pipettes and Test Tubes Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Laboratory Plastic Pipettes and Test Tubes Market Value (USD Million) By Region

Table 10: Global Laboratory Plastic Pipettes and Test Tubes Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Laboratory Plastic Pipettes and Test Tubes Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Laboratory Plastic Pipettes and Test Tubes Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Laboratory Plastic Pipettes and Test Tubes Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Corning Basic Information And Sales Area

Table 31: Corning. Products Portfolio

Table 32: Kartell Basic Information And Sales Area

Table 33: Kartell. Products Portfolio

Table 34: BRAND Basic Information And Sales Area

Table 35: BRAND. Products Portfolio

Table 36: VITLAB Basic Information And Sales Area

Table 37: VITLAB. Products Portfolio

Table 38: Thermo Fisher Scientific Basic Information And Sales Area

Table 39: Thermo Fisher Scientific. Products Portfolio

Table 40: SPL life sciences Basic Information And Sales Area

Table 41: SPL life sciences. Products Portfolio

Table 42: Sanplatec Corporation Basic Information And Sales Area

Table 43: Sanplatec Corporation. Products Portfolio

Table 44: DWK Life Sciences Company Basic Information And Sales Area

Table 45: DWK Life Sciences Company. Products Portfolio

Table 46: Sarstedt Basic Information And Sales Area

Table 47: Sarstedt. Products Portfolio

Table 48: Greiner Bio-One Basic Information And Sales Area

Table 49: Greiner Bio-One. Products Portfolio

Table 50: WATSON Bio Lab Basic Information And Sales Area

Table 51: WATSON Bio Lab. Products Portfolio

Table 52: VWR Basic Information And Sales Area

Table 53: VWR. Products Portfolio

Table 54: Sorfa Basic Information And Sales Area

Table 55: Sorfa. Products Portfolio

Table 56: Nest Basic Information And Sales Area

Table 57: Nest. Products Portfolio

Table 58: Guangzhou Jet Bio-Filtration Basic Information And Sales Area

Table 59: Guangzhou Jet Bio-Filtration. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Laboratory Plastic Pipettes and Test Tubes Market Value (USD Million) By Region

Table 65: Global Laboratory Plastic Pipettes and Test Tubes Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

FAQs

1. What is the current Laboratory Plastic Pipettes and Test Tubes market size?

The Laboratory Plastic Pipettes and Test Tubes market size surpassed USD 2.4 billion in 2023, driven by rising global R&D spend and high-throughput screening labs demanding low-cost, disposable consumables across biopharma, clinical and academic segments.

2. What growth forecast and future outlook can stakeholders expect?

Analysts project a 6.3% CAGR through 2030, lifting the market past USD 3.7 billion. The future outlook is underpinned by personalized medicine, biologics upsurge and emerging-market diagnostic expansion, offsetting price-based competition and raw-material volatility.

3. Which key drivers are accelerating demand for plastic pipettes and test tubes?

Key drivers include single-use plastic preference to curb contamination, surge in point-of-care testing, biobanking expansions, vaccine-scale manufacturing and cost advantages over glass. Sustainability mandates also push bio-based resins, widening Laboratory Plastic Pipettes and Test Tubes market size.

4. What challenges restrain Laboratory Plastic Pipettes and Test Tubes market growth?

Challenges include volatile polypropylene prices, strict medical-plastic recycling rules, supply-chain disruptions for certified resins, price pressure from low-cost Asian makers and paucity of cGMP custom molding capacity in developing regions.

5. Which regions currently lead consumption and production?

North America holds 38% share led by U.S. biopharma clusters; Europe follows with Germany, Switzerland and Netherlands dominating exports; China and India are fastest-growing producers, leveraging contract manufacturing to serve global OEMs.

6. Who are the top companies shaping the competitive landscape?

Thermo Fisher, Eppendorf, Corning, Sarstedt, BRAND and VWR dominate the Laboratory Plastic Pipettes and Test Tubes market size with broad portfolios, while Greiner Bio-One, SPL Life Sciences and Nest Scientific lead cost-efficient, private-label supply.

7. What future opportunities will unlock incremental value?

Opportunities include recycled polypropylene adoption, customized low-retention pipette tips for NGS workflows, 3-D printed micro-tubes for organoid culture, and integrated RFID tracking in test tubes to support smart-lab digitalization and sample chain-of-custody.

8. How is technology impacting product design and performance?

Automation-compatible racks, robotic tip reload systems, ultra-clear virgin resins for optical assays and laser-etched barcodes are elevating precision and throughput, directly influencing Laboratory Plastic Pipettes and Test Tubes market growth forecasts.

9. What does the regulatory landscape require for market access?

Products must meet USP Class VI, ISO 13485, FDA 21 CFR and EU Regulation 10/2011 for food-contact and IVDR traceability; REACH compliance for phthalate-free resins and impending EU medical-device database (EUDAMED) registration are shaping procurement specs.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Laboratory Plastic Pipettes and Test Tubes Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 billion
Revenue forecast in 2033	7.38 billion
Growth rate	CAGR of 7.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Corning; Kartell; BRAND; VITLAB; Thermo Fisher Scientific; SPL life sciences; Sanplatec Corporation; DWK Life Sciences Company; Sarstedt; Greiner Bio-One; WATSON Bio Lab; VWR; Sorfa; Nest; Guangzhou Jet Bio-Filtration
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options